收稿日期: 2019-05-21
网络出版日期: 2019-06-24
基金资助
国家自然科学基金资助项目(81722008);国家自然科学基金资助项目(91639101);国家自然科学基金资助项目(81570362);上海市教委科研创新计划自然科学重大资助项目(2017-01-07-00-09-E00042);上海市科委部分地方院校能力建设资助项目(17010500100);上海市国际科技合作基金资助项目(18410722200)
Non-coding RNAs in exercise-induced cardiac hypertrophy
Received date: 2019-05-21
Online published: 2019-06-24
大量研究表明运动训练对心脏具有保护作用. 运动可诱导生理性心肌肥厚,对于心力衰竭具有保护作用. 心肌肥厚可分为生理性和病理性心肌肥厚,后者可导致心脏功能受损、心力衰竭以及高死亡率. 近几十年来,非编码 RNA 包括微小 RNA (microRNA, miRNAs)、长链非编码 RNA (long noncodingRNA, lncRNAs) 和环状 RNA (circularRNA, circRNAs) 等,引起了研究者的极大关注,非编码 RNA 的失调被证实与多种心血管疾病密切相关. 综述了心肌肥厚,尤其是生理性心肌肥厚中 miRNAs,lncRNAs 和 circRNAs 的特征、功能和分子机制.同向调控这些运动影响的非编码 RNA 可以防治心力衰竭.
王天慧, 肖俊杰 . 运动诱导生理性心肌肥厚的非编码RNA调节机制[J]. 上海大学学报(自然科学版), 2019 , 25(3) : 425 -434 . DOI: 10.12066/j.issn.1007-2861.2140
Increasing evidence supports the protective role of exercise training in preventing cardiovascular diseases. Exercise induces physiological cardiac growth, and thus protects the heart against pathological remodeling and heart failure. Cardiac hypertrophy falls into two types, namely, the physiological cardiac hypertrophy and the pathological cardiac hypertrophy, and the latter can result in impaired cardiac functioning, heart failure and is predictive of a higher incidence of death due to cardiovascular diseases. Non-coding RNAs (ncRNAs) including microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) have drawn significant attention over the last couple of decades, and their dysregulation is increasingly being linked to many cardiovascular diseases. In this paper, the profiling function, and molecular mechanism of miRNAs, lncRNAs, and circ- RNAs in cardiac hypertrophy, especially in physiological hypertrophy have been analyzed. Targeting these ncRNAs represents novel therapy for heart failure.
| [1] | Roth G A, Johnson C, Abajobir A , et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015[J]. J Am Coll Cardiol, 2017,70(1):1-25. |
| [2] | 胡盛寿, 高润霖, 刘力生 , 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019,34(3):209-219. |
| [3] | Sharma S, Merghani A, Mont L . Exercise and the heart: the good, the bad, and the ugly[J]. European Heart Journal, 2015,36(23):1445-1453. |
| [4] | Gomes C P C, De Gonzalo-Calvo D, Toro R , et al. Non-coding RNAs and exercise: pathophysiological role and clinical application in the cardiovascular system[J]. Clinical Science, 2018,132(9):925-942. |
| [5] | Raimondo D D, Miceli G, Musiari G , et al. New insights about the putative role of myokines in the context of cardiac rehabilitation and secondary cardiovascular prevention[J]. Ann Transl Med, 2017,5(15):300. |
| [6] | Birney E, Stamatoyannopoulos J A, Dutta A , et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project[J]. Nature, 2007,447:799-816. |
| [7] | Zaratiegui M, Irvine D V, Martienssen R A . Noncoding RNAs and gene silencing[J]. Cell, 2007,128(4):763-776. |
| [8] | Ottaviani L, Martins P A D C. Non-coding RNAs in cardiac hypertrophy[J]. The Journal of Physiology, 2017,595(12):4037-4050. |
| [9] | Bang C, Batkai S, Dangwal S , et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy[J]. Journal of Clinical Investigation, 2014,124(5):2136-2146. |
| [10] | Djebali S, Davis CA, Merkel A , et al. Landscape of transcription in human cells[J]. Nature, 2012,489:101-108. |
| [11] | Eding J E C, Demkes C J, Lynch J M , et al. The efficacy of cardiac anti-miR-208a therapy is stress dependent[J]. Molecular Therapy, 2017,25(3):694-704. |
| [12] | Anderson L, Oldridge N, Thompson D R , et al. Exercise-based cardiac rehabilitation for coronary heart disease: cochrane systematic review and Meta-analysis[J]. Journal of the American College of Cardiology, 2016,67(1):1-12. |
| [13] | Ellison G M, Waring C D, Vicinanza C , et al. Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms[J]. Heart, 2012,98(1):5-10. |
| [14] | Weiner R B, Baggish A L . Exercise-induced cardiac remodeling[J]. Progress in Cardiovascular Diseases, 2012,54(5):380-386. |
| [15] | Van R E . The art of microRNA research[J]. Circulation Research, 2011,108(2):219-234. |
| [16] | Farh K K, Grimson A, Jan C , et al. The widespread impact of mammalian microRNAs on mRNA repression and evolution[J]. Science, 2005,310(5755):1817-1821. |
| [17] | Griffiths-Jones S, Saini H K, Van Dongen S , et al. MiRBase: tools for microRNA genomics[J]. Nucleic Acids Res, 2008,36:D154-D158. |
| [18] | Wang K C, Chang H Y . Molecular mechanisms of long noncoding RNAs[J]. Molecular Cell, 2011,43(6):904-914. |
| [19] | Wilusz J E, Jnbaptiste C K, Lu L Y , et al. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails[J]. Genes & Development, 2012,26(21):2392-2407. |
| [20] | Schonrock N, Harvey R P, Mattick J S . Long noncoding RNAs in cardiac development and pathophysiology[J]. Circulation Research, 2012,111(10):1349-1362. |
| [21] | Qu S, Yang X, Li X , et al. Circular RNA: a new star of noncoding RNAs[J]. Cancer Letters, 2015,365(2):141-148. |
| [22] | Hsiao K Y, Sun H S, Tsai S J . Circular RNA: new member of noncoding RNA with novel functions[J]. Experimental Biology & Medicine, 2017,242(11):1136-1141. |
| [23] | Tay Y, Rinn J, Pandolfi P P . The multilayered complexity of ceRNA crosstalk and competition[J]. Nature, 2014,505(7483):344-352. |
| [24] | Du W W, Zhang C, Yang W , et al. Identifying and characterizing circRNA-protein interaction[J]. Theranostics, 2017,7(17):4183-4191. |
| [25] | Li Z, Huang C, Bao C , et al. Exon-intron circular RNAs regulate transcription in the nucleus[J]. Nat Struct Mol Biol, 2015,22(3):256-264. |
| [26] | Ashwal-Fluss R, Meyer M, Pamudurti N R , et al. CircRNA biogenesis competes with pre-mRNA splicing[J]. Molecular Cell, 2014,56(1):55-66. |
| [27] | Qu S, Zhong Y, Shang R , et al. The emerging landscape of circular RNA in life processes[J]. RNA Biology, 2016,14(8):1-8. |
| [28] | Ramasamy S, Velmurugan G, Shanmugha R K , et al. MiRNAs with apoptosis regulating potential are differentially expressed in chronic exercise-induced physiologically hypertrophied hearts[J]. PLoS One, 2015,10(3):e0121401. |
| [29] | Fernandes T, Hashimoto N Y, Magalh$\tilde{a}$es F C, et al. Aerobic exercise training-induced left ventricular hypertrophy involves regulatory microRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7)[J]. Hypertension, 2011,58(2):182-189. |
| [30] | Car$\grave{e}$ A, Catalucci D, Felicetti F , et al. MicroRNA-133 controls cardiac hypertrophy[J]. Nature Medicine, 2007,13(5):613-618. |
| [31] | Ma Z, Qi J, Meng S , et al. Swimming exercise training-induced left ventricular hypertrophy involves microRNAs and synergistic regulation of the PI3K/AKT/mTOR signaling pathway[J]. European Journal of Applied Physiology, 2013,113(10):2473-2486. |
| [32] | Yang L, Li Y, Wang X , et al. Overexpression of miR-223 tips the balance of pro- and anti-hypertrophic signaling cascades toward physiologic cardiac hypertrophy[J]. Journal of Biological Chemistry, 2016,291:15700-15713. |
| [33] | Wang L, Lv Y, Li G , et al. MicroRNAs in heart and circulation during physical exercise[J]. Journal of Sport and Health Science, 2018,7(4):433-441. |
| [34] | Soci U P, Fernandes T, Barauna V G , et al. Epigenetic control of exercise training-induced cardiac hypertrophy by miR-208[J]. Clinical Science, 2016,130(22):2005-2015. |
| [35] | Soci U P, Fernandes T, Hashimoto N Y , et al. MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats[J]. Physiological Genomics, 2011,43(11):665-673. |
| [36] | Lin R C, Weeks K L, Gao X M , et al. PI3K (p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA[J]. Arteriosclerosis, Thrombosis, and Vascular Biology, 2010,30(4):724-732. |
| [37] | Van Rooij E, Sutherland L B, Thatcher J E , et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis[J]. Proceedings of the National Academy of Sciences, 2008,105(35):13027-13032. |
| [38] | Da Silva N D, Fernandes T, Soci U P , et al. Swimming training in rats increases cardiac microRNA-126 expression and angiogenesis[J]. Med Sci Sports Exerc, 2012,44:1453-1462. |
| [39] | Liu X, Xiao J, Zhu H , et al. miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling[J]. Cell Metabolism, 2015,21(4):584-595. |
| [40] | Shi J, Bei Y, Kong X , et al. MiR-17-3p contributes to exercise-induced cardiac growth and protects against myocardial ischemia-reperfusion injury[J]. Theranostics, 2017,7(3):664-676. |
| [41] | Zhao Y, Li H, Fang S , et al. NONCODE 2016: an informative and valuable data source of long non-coding RNAs[J]. Nucleic Acids Research, 2015,44(D1):D203-D208. |
| [42] | Sun L, Zhang Y, Zhang Y , et al. Expression profile of long non-coding RNAs in a mouse model of cardiac hypertrophy[J]. International Journal of Cardiology, 2014,177(1):73-75. |
| [43] | Li X, Zhang L, Liang J . Unraveling the expression profiles of long noncoding RNAs in rat cardiac hypertrophy and functions of lncRNA BC088254 in cardiac hypertrophy induced by transverse aortic constriction[J]. Cardiology, 2016,134(2):84-98. |
| [44] | Yang K C, Yamada K A, Patel A Y , et al. Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support[J]. Circulation, 2014,129(9):1009-1021. |
| [45] | Han P, Li W, Lin C H , et al. A long noncoding RNA protects the heart from pathological hypertrophy[J]. Nature, 2014,514:102-106. |
| [46] | Wang Z, Zhang X J, Ji Y X , et al. The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy[J]. Nature Medicine, 2016,22:1131-1139. |
| [47] | Lv L, Li T, Li X , et al. LncRNA Plscr4 controls cardiac hypertrophy by regulating miR-214[J]. Mol Ther Nucleic Acids, 2017,10:387-397. |
| [48] | Li Y, Liang Y, Zhu Y , et al. Noncoding RNAs in cardiac hypertrophy[J]. Journal of Cardiovascular Translational Research, 2018,11:439-449. |
| [49] | Wang L, Meng X, Li G , et al. Circular RNAs in cardiovascular diseases [J]. [J]. Adv Exp Med Biol, 2018,1087:191-204. |
| [50] | Zhou Q, Zhang Z, Bei Y , et al. Circular RNAs as novel biomarkers for cardiovascular diseases[J]. Adv Exp Med Biol, 2018,1087:159-170. |
| [51] | Werfel S, Nothjunge S, Schwarzmayr T , et al. Characterization of circular RNAs in human, mouse and rat hearts[J]. J Mol Cell Cardiol, 2016,98:103-107. |
| [52] | Tan W L W, Lim B T S, Anene-Nzelu C G O , et al. A landscape of circular RNA expression in the human heart[J]. Cardiovasc Res, 2017,113:298-309. |
/
| 〈 |
|
〉 |
